SENEXON-S- docusate sodium -sennosides tablet, coated

SENEXON-S by

Drug Labeling and Warnings

SENEXON-S by is a Otc medication manufactured, distributed, or labeled by NCS HealthCare of KY, Inc dba Vangard Labs. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredients (in each tablet)

Docusate sodium 50 mg

Sennosides 8.6 mg

Purposes

Stool Softener

Stimulant Laxative 

Uses

• relieves occasional constipation

• generally produces bowel movement in  6-12 hours

Warnings

Do not use

• if you are taking mineral oil
• for longer than one week
• when abdominal pain, nausea or vomiting are present

Ask a doctor before use if you

have a sudden change in bowel habits that lasts over two weeks

Ask a doctor or pharmacist before use if you are

taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.

Stop use and ask a doctor if

• you fail to have a bowel movement after use of this product
• you have rectal bleeding  

These may indicate a serious condition.

If pregnant or breast-feeding

ask a health professional before use.

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• take preferably at bedtime or as directed by a doctor

• if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maxiumum dosage)

age	starting dosage	maximum dosage
adults and children 12 years and older	2 tablets once daily	4 tablets twice daily
children 6 to under 12 years	1 tablet once daily	2 tablets twice daily
children 2 to under 6 years	1/2 tablet once daily	1 tablet twice daily
children under 2 years	ask a doctor	ask a doctor

Other information

• each tablet contains: calcium 20mg, sodium 6 mg (LOW SODIUM)
• store at 20º - 25ºC (68º - 77ºF)

*Rugby Laboratories is not affiliated with the owner of the registered trademark Senokot-S®.

192R R-14 Rev. 02/13

Questions or comments?

 1-800-645-2158 

Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium,

D&C yellow #10 aluminum lake, dibasic calcium phosphate

dihydrate, FD&C yellow #6 aluminum lake, hypromellose,

magnesium stearate, microcrystalline cellulose, polyethylene

glycol, sodium benzoate, stearic acid, titanium dioxide

Principal Display Panel

 

INGREDIENTS AND APPEARANCE

SENEXON-S 
docusate sodium -sennosides tablet, coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 0615-8083(NDC: 0536-4086)
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN)	SENNOSIDES A AND B	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
CARNAUBA WAX (UNII: R12CBM0EIZ)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
HYPROMELLOSES (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
SODIUM BENZOATE (UNII: OJ245FE5EU)
STEARIC ACID (UNII: 4ELV7Z65AP)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	ORANGE	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	TCL081
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 0615-8083-39	30 in 1 BLISTER PACK; Type 0: Not a Combination Product	12/20/2016	08/31/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part334	03/16/2011	08/31/2020

Labeler - NCS HealthCare of KY, Inc dba Vangard Labs (050052943)

Establishment
Name	Address	ID/FEI	Business Operations
NCS HealthCare of KY, Inc dba Vangard Labs		050052943	REPACK(0615-8083)